PRIME Federal Hematology Webinar Series
Join AMSUS for the Prime Federal Hematology webinar series. Each webinar offers CME/CE opportunities for physicians, physicians assistants, nurse practitioners, pharmacists, nurses, and case managers.
21 October 2021
Advances in the Evolving Treatment Landscape for Chronic Lymphocytic Leukemia
Time: 6:00pm EST
Join in this live session with a case-based discussion applying the latest evidence in Chronic Lymphocytic Leukemia (CLL) treatment and management with a focus on tackling unique considerations for care in federal, public, and government healthcare settings.
Speakers:
Paul M Barr, MD
Medical Director, Clinical Trials Office
Wilmot Cancer Institute
Associate Professor of Hematology/Oncology
University of Rochester Medical Center
Rochester, NY
Susan M O’Brien, MD
Medical Director, Stern Center for Cancer Clinical Trials and Research
Professor, Division of Hematology/Oncology
Associate Director, Clinical Science
Chao Family Comprehensive Cancer Center
University of California, Irvine
Orange, CA
Ryan J Atkinson, PharmD, MBA
Senior Director of Specialty Pharmacy Strategy
Maxor National Pharmacy Services, LLC
Indianapolis, IN
16 November 2022
Harnessing the Potential of Novel Treatment Approaches in Non-Hodgkin Lymphoma
5:00 pm EST
This live session is designed to provide an in-depth look at the latest evidence in Non-Hodgkin Lymphoma (NHL) treatment and management with a focus on care in federal, public, and government healthcare settings. Using real-world patient cases, experts will share practical strategies for optimizing patient care in NHL.
Speakers:
Caron A Jacobson, MD
Medical Director, Immune Effector Cell Therapy Program
Dana Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School
Boston, MA
Peter Martin, MD
Associate Professor of Medicine
Division of Hematology/Oncology
Chief, Lymphoma Program
Weill Cornell Medicine
New York, NY
Ryan J Atkinson, PharmD, MBA
Senior Director of Specialty Pharmacy Strategy
Maxor National Pharmacy Services, LLC
Indianapolis, IN
15 December 2021
Expert Approaches in Myelodysplastic Syndromes, Myelofibrosis, and Acute Myeloid Leukemia
5:00 pm EST
New advances in treatment for Myelodysplastic Syndromes, Myelofibrosis, and Acute Myeloid Leukemia are poised to transform outcomes for patients with these hematologic malignancies. In this live webinar, hear leading experts discuss the latest evidence along with case examples for application to clinical practice.
Speakers:
Joshua F Zeidner, MD
Assistant Professor of Medicine
Division of Hematology/Oncology
UNC Lineberger Comprehensive Cancer Center
The University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, NC
Daniel A Pollyea, MD, MS
Clinical Director, Leukemia Services
Robert H Allen, MD Chair in Hematology Research
Associate Professor of Medicine, Division of Hematology
University of Colorado School of Medicine
Aurora, CO
Ryan J Atkinson, PharmD, MBA
Senior Director of Specialty Pharmacy Strategy
Maxor National Pharmacy Services, LLC
Indianapolis, IN
20 January 2022
Emerging Evidence and State-of-the-Art Care for Multiple Myeloma
6:00 pm EST
Expert-led case discussions are highlighted in this live webinar exploring new data in Multiple Myeloma treatment. Don’t miss this opportunity to hear expert analysis of the latest evidence and implications for care in federal and public health settings.
Speakers:
Joseph R Mikhael, MD, MEd, FRCPC, FACP
Professor, Division of Applied Cancer Research and Drug Discovery
Translational Genomics Research Institute (TGen)
City of Hope Comprehensive Cancer Center
Phoenix, AZ
Rafael Fonseca, MD
Getz Family Professor of Cancer
Director, Innovation and Transformational Relationships
Interim Executive Director
Mayo Clinic Comprehensive Cancer Center
Phoenix, AZ
William Wachsman, MD, PhD
Professor of Clinical Medicine
Division of Hematology-Oncology
University of California San Diego School of Medicine
Research Scientist, Veterans Medical Research Foundation of San Diego
Staff Physician, Section of Hematology/Oncology
VA San Diego Health Care System
San Diego, CA
15 February 2022
CAR T-Cell Therapies: Special Considerations for Federal and Public Health Settings
5:00 pm EST
As CAR T-Cell approaches revolutionize treatment for hematologic malignancies, unique challenges arise in federal and public health settings. Join this live session to hear the latest evidence and expert insights on practical considerations for integrating CAR T-Cell Therapies into treatment for patients with hematologic malignancies.
Speakers:
Larry D Anderson, Jr, MD, PhD
Director of the Myeloma, Waldenström’s, and Amyloidosis Program
Associate Professor of Internal Medicine
Division of Hematology/Oncology
UT Southwestern Medical Center
Dallas, TX
Ryan J Atkinson, PharmD, MBA
Senior Director of Specialty Pharmacy Strategy
Maxor National Pharmacy Services, LLC
Indianapolis, IN
